AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE
Pre-Launchamlodipine maleate; benazepril hydrochloride
NDAORALCAPSULE
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Amlodipine maleate and benazepril hydrochloride is a fixed-dose combination antihypertensive agent that pairs a calcium channel blocker with an ACE inhibitor. This combination treats hypertension by reducing blood pressure through dual mechanisms: amlodipine dilates blood vessels while benazepril inhibits angiotensin conversion. The product is currently in pre-launch stage under NDA review by Dr. Reddy's Laboratories.
Pre-Launch
Pre-launch phase suggests limited commercial infrastructure; teams will scale rapidly post-approval with focus on market entry strategy and physician education.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on this pre-launch combination therapy offers early-career exposure to antihypertensive market dynamics and fixed-dose combination strategy. Professionals joining now will build the commercial infrastructure from ground zero, requiring strong cross-functional collaboration and market positioning skills in a competitive category.
Brand ManagerField Sales Representative
Worked on AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.